-
Talk to Us: info@nidccglobal.org
-
Location: Washington, DC | Abuja, Nigeria
Language:
Everyday Economic News
PICS INVESTOR NOTICE: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against PicS N.V. for investors who purchased Class A common stock during its January 30, 2026 IPO and suffered substantial losses. The lawsuit alleges that PicS N.V. made false or misleading statements in its offering documents regarding its credit evaluation procedures, unreported Stage 3 formation rates, and the quality of its credit models. Investors have until August 4, 2026, to seek appointment as lead plaintiff.
SpaceX Closes Up 19% — Secures MSCI, FTSE Fast-Track Index Inclusion
SpaceX (SPCX) debuted on Nasdaq with a 19% gain on its first day of trading, leading to its fast-track inclusion in key benchmarks by FTSE Russell and MSCI. FTSE Russell will add SpaceX to the Russell US Index Series effective June 26, 2026, while MSCI will include it in its standard and large-cap indexes effective June 29. These inclusions are expected to generate significant demand from passive funds, although S&P Dow Jones Indices has ruled out immediate inclusion in the S&P 500 due to its profitability criteria.
Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC Filing
Bioaffinity Technologies has announced an offering of 2.63 million shares of its common stock, as detailed in a recent SEC filing. This information was reported by Refinitiv and is a critical development for the company's investors and the financial market.
Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand
Leverage Shares by Themes has introduced two new ETFs, the Leverage Shares 2X Long SpaceX Daily ETF (SPCH) and the Leverage Shares 2X Short SpaceX Daily ETF (SSPC), to meet significant retail demand following SpaceX's historic IPO. Both funds offer daily leveraged exposure to SpaceX stock with a highly competitive management fee of 0.75%, aiming to provide cost-effective tools for active traders and sophisticated investors. This launch is positioned to disrupt the market by offering lower fees compared to established industry averages for similar leveraged single-stock ETFs.
[S-1] bioAffinity Technologies, Inc. Files IPO Registration Statement
bioAffinity Technologies, Inc. has filed an S-1 registration statement for an IPO, offering 2,631,579 shares of common stock, pre-funded, and placement agent warrants at an assumed price of $1.52 per share, aiming to raise approximately $3.4 million for working capital and general corporate purposes. The company specializes in noninvasive lung diagnostics, featuring its CyPath® Lung test, which demonstrated high sensitivity and specificity for small pulmonary nodules. Despite recent revenue growth and clinical advancements, the company faces substantial doubt about its ability to continue as a going concern without additional financing, with existing cash projected to last only until June 2026.
Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
Bitmine Immersion Technologies, Inc. (NYSE: BMNR) has announced that its Board of Directors has declared the initial cash dividends for its 9.50% Series A Perpetual Preferred Stock. An NYSE listing has also been secured for this Series A Preferred Stock. Further details are available on newswire.ca.
Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock
Bitmine Immersion Technologies announced its Board of Directors has declared initial cash dividends for its 9.50% Series A Perpetual Preferred Stock. The initial dividend of $0.316667 per share is payable on June 22, 2026, and a second weekly dividend of $0.105556 per share is payable on June 26, 2026. The Series A Preferred Stock has also been approved for listing on the New York Stock Exchange under the ticker symbol "BMNP", with trading expected to begin on June 16, 2026.